| Oral Tyrosine Multi-kinase Inhibitor, Pazopanib, Active in ... - Cancer Consultants |
|
|
Cancer ConsultantsResearchers from Europe have reported that pazopanib is an active new tyrosine kinase inhibitor for treating renal cell carcinoma. The details of this study ... read more |